dm+d
703957003
Articles
What rationale, guidance and evidence is there for the use of phosphodiesterase-5 inhibitors as supportive therapy to rehabilitate erectile function after nerve sparing radical prostatectomy?
8 May 2019
Erectile dysfunction is a common complication following prostatectomy. Phosphodiesterase 5 inhibitors (sildenafil, tadalafil, vardenafil or avanafil), used either daily or on demand following prostatectomy, have…